RxCoQ-CF 60 gelcaps

Energy Production & Cardiovascular Support

Special crystal free form of CoQ10. It supports cardiac function through mithocondrial energy production.  It is also supportive to the organs requiring a lot of energy e.g. the heart muscle, periodontal tissues and the body's defense system. Functions as a powerful fat soluble antioxidant providing protection against free radicals attack.

More details

Customers who bought this product also bought:

Coenzyme Q10 is present in almost all cells, where it is necessary for mitochondrial energy production. The body’s highest concentrations of Coenzyme Q10 (CoQ10) are found in the heart, where constant chemical energy availability is imperative.

In addition to its benefits for cardiac function through energy production, CoQ10 also functions as a powerful fat soluble antioxidant, providing protection against free radical attack for vascular structures, as well as for other issues.

RxCoQ-CF is a unique patent-pending formula of CoQ10, food grade d-limonene (which serves to solubilize CoQ10), and tocopherol (vitamin E). This combination creates a liquid, crystal-free solution of CoQ10 that provides enhanced bioavailability. By improving dissolution, absorption is enhanced.

Standard Dosage:  Take one capsule daily or as directed by your healthcare practitioner.

These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease.

Supplement Facts

Write your review

RxCoQ-CF   60 gelcaps

RxCoQ-CF 60 gelcaps

Energy Production & Cardiovascular Support

Special crystal free form of CoQ10. It supports cardiac function through mithocondrial energy production.  It is also supportive to the organs requiring a lot of energy e.g. the heart muscle, periodontal tissues and the body's defense system. Functions as a powerful fat soluble antioxidant providing protection against free radicals attack.

Write your review

  1. Potential role of ubiquinone (coenzyme Q10) in pediatric cardiomyopathy. Bhagavan HN, Chopra RK. Clin Nutr.Jun 2005;24(3):331-338.
  2. Cofactor treatment improves ATP synthetic capacity in patients with oxidative phosphorylation disorders. Marriage BJ, Clandinin MT, Macdonald IM, Glerum DM. Mol Genet Metab. Apr 2004;81(4):263-272.
  3. The expanding phenotype of mitochondrial myopathy. DiMauro S, Gurgel-Giannetti J. Curr Opin Neurol. Oct 2005;18(5):538-542.
  4. Mitochondrial dysfunction and oxidative damage in Alzheimer's and Parkinson's diseases and coenzyme Q10 as a potential treatment. Beal MF. J Bioenerg Biomembr. Aug 2004;36(4):381-386.
  5. Coenzyme Q10 serum levels in Huntington's disease. Andrich J, Saft C, Gerlach M, et al. J Neural Transm Suppl. 2004(68):111-116.
  6. Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy. Ogasahara S, Engel AG, Frens D, Mack D. Proc Natl Acad Sci U S A. Apr 1989;86(7):2379-2382.
  7. Efficacy of coenzyme Q10 for improved tolerability of cancer treatments: a systematic review. Roffe L, Schmidt K, Ernst E. J Clin Oncol. Nov 1 2004;22(21):4418-4424.
  8. Considerations for supplementing with coenzyme Q10 during statin therapy. Levy HB, Kohlhaas HK. Ann Pharmacother. Feb 2006;40(2):290-294.
  9. Tolerance of high-dose (3,000 mg/day) coenzyme Q10 in ALS. Ferrante KL, Shefner J, Zhang H, et al. Neurology. Dec 13 2005;65(11):1834-1836.
  10. Molyneux SL, Florkowski CM, George PM, et al. (October 2008). "Coenzyme Q10: an independent predictor of mortality in chronic heart failure". J. Am. Coll. Cardiol. 52 (18): 1435–41. doi:10.1016/j.jacc.2008.07.044. PMID 19017509. [verification needed]
  11. Witztum, JL (1994). "The oxidation hypothesis of atherosclerosis". Lancet 344 (8925): 793–5. doi:10.1016/S0140-6736(94)92346-9. PMID 7916078. 
  12. Parthasarathy, S; Steinberg, D; Witztum, JL (1992). "The role of oxidized low-density lipoproteins in the pathogenesis of atherosclerosis". Annual review of medicine 43: 219–25. doi:10.1146/annurev.me.43.020192.001251. PMID 1580586. 
  13. Heller, FR; Descamps, O; Hondekijn, JC (1998). "LDL oxidation: therapeutic perspectives". Atherosclerosis. 137 Suppl: S25–31. doi:10.1016/S0021-9150(97)00308-0. PMID 9694538. 
  14. Alleva R, Tomasetti M, Battino M, Curatola G, Littarru GP, Folkers K (September 1995). "The roles of coenzyme Q10 and vitamin E on the peroxidation of human low density lipoprotein subfractions". Proc. Natl. Acad. Sci. U.S.A. 92 (20): 9388–91. doi:10.1073/pnas.92.20.9388. PMC 40990. PMID 7568138. 
  15. Rozen, TD; Oshinsky, ML; Gebeline, CA; Bradley, KC; Young, WB; Shechter, AL; Silberstein, SD (2002). "Open label trial of coenzyme Q10 as a migraine preventive". Cephalalgia 22 (2): 137–41. doi:10.1046/j.1468-2982.2002.00335.x. PMID 11972582. 
  16. Sándor, PS; Di Clemente, L; Coppola, G; Saenger, U; Fumal, A; Magis, D; Seidel, L; Agosti, RM et al. (2005). "Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial". Neurology 64 (4): 713–5. doi:10.1212/01.WNL.0000151975.03598.ED. PMID 15728298. 
  17. Sakano, K; Takahashi, M; Kitano, M; Sugimura, T; Wakabayashi, K (2006). "Suppression of azoxymethane-induced colonic premalignant lesion formation by coenzyme Q10 in rats". Asian Pacific journal of cancer prevention : APJCP 7 (4): 599–603. PMID 1725043
  18. Damian, M. S.; Ellenberg, D; Gildemeister, R; Lauermann, J; Simonis, G; Sauter, W; Georgi, C (2004). "Coenzyme Q10 Combined With Mild Hypothermia After Cardiac Arrest: A Preliminary Study". Circulation 110 (19): 3011–6. doi:10.1161/01.CIR.0000146894.45533.C2. PMID 15520321. 
  19. Tracy, Melanie Johns (2003). "Ch. 4: Coenzyme Q10 (Ubiquinone, Ubidecarenone)". Dietary supplements: toxicology and clinical pharmacology. Humana Press. pp. 53–85. ISBN 978-1-58829-014-4. 
  20. Rosenfeldt, F L; Haas, S J; Krum, H; Hadj, A; Ng, K; Leong, J-Y; Watts, G F (2007). "Coenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials". Journal of Human Hypertension 21 (4): 297–306. doi:10.1038/sj.jhh.1002138. PMID 17287847. 
  21. T.L.P. Watts, BDS, MDS, PhD, FDS, Department of Periodontology and Preventive Dentistry, UMDS, Guy's Hospital London (1995). "Coënzyme Q10 and periodontal treatment: is there any beneficial effect?". British Dental Journal 178: 209–213. 
  22. Folkers, K; Hanioka, T; Xia, L; McReejr, J; Langsjoen, P (1991). "Coenzyme Q10 increases T4/T8 ratios of lymphocytes in ordinary subjects and relevance to patients having the aids related complex". Biochemical and Biophysical Research Communications 176 (2): 786–91. doi:10.1016/S0006-291X(05)80254-2. PMID 1673841. 
  23. Littarru GP, Nakamura R, Ho L, Folkers K, Kuzell WC (October 1971). "Deficiency of Coenzyme Q10 in Gingival Tissue from Patients with Periodontal Disease". Proc. Natl. Acad. Sci. U.S.A. 68 (10): 2332–5. doi:10.1073/pnas.68.10.2332. PMC 389415. PMID 5289867. 
  24. Nakamura R, Littarru GP, Folkers K, Wilkinson EG (April 1974). "Study of CoQ10-Enzymes in Gingiva from Patients with Periodontal Disease and Evidence for a Deficiency of Coenzyme Q10". Proc. Natl. Acad. Sci. U.S.A. 71 (4): 1456–60. doi:10.1073/pnas.71.4.1456. PMC 388248. PMID 4151519. 
  25. McRee JT, Hanioka T, Shizukuishi S, Folkers K (1993). "Therapy with coenzyme Q10 for patients with periodontal disease". J Dent Health 43 (5): 659–666. doi:10.5834/jdh.43.659. 
  26. Hanioka T, Tanaka M, Ojima M, Shizukuishi S, Folkers K (1994). "Effect of topical application of coenzyme Q10 on adult periodontitis". Mol. Aspects Med. 15 (Suppl): S241–8. doi:10.1016/0098-2997(94)90034-5. PMID 7752836. 
  27. Wilkinson, EG; Arnold, RM; Folkers, K (1976). "Bioenergetics in clinical medicine. VI. adjunctive treatment of periodontal disease with coenzyme Q10". Research communications in chemical pathology and pharmacology 14 (4): 715–9. PMID 785563.
  28. Kees Karsten, Dennis Verhoeve, Bruno Loos en Sacha Eikenboom. (1997). "Fabrikant misleidt parodontitis patiënten met Q10. Wetenschappelijke onderbouwing van vermeend effect ontbreekt.". Nederlands Tandartsenblad (7): 52. 
  29. Kees Karsten, Dennis Verhoeve, Bruno Loos en Sacha Eikenboom. Fabrikant Bio-Quinon Q10 veroordeeld. KAG, consumentenbond en NVvP tevreden over uitspraak rechter. Nederlands Tandartsenblad 52/21/1997
  30. Quiles, J; Ochoa, JJ; Huertas, JR; Mataix, J (2004). "Coenzyme Q supplementation protects from age-related DNA double-strand breaks and increases lifespan in rats fed on a PUFA-rich diet". Experimental Gerontology 39 (2): 189–94. doi:10.1016/j.exger.2003.10.002. PMID 15036411. 
  31. Coles L, Harris S (1996). "Coenzyme Q-10 and Lifespan Extension". Advances in Anti-Aging Medicine 1 (1): 205–15. 
  32. Lönnrot, K; Holm, P; Lagerstedt, A; Huhtala, H; Alho, H (1998). "The effects of lifelong ubiquinone Q10 supplementation on the Q9 and Q10 tissue concentrations and life span of male rats and mice". Biochemistry and molecular biology international 44 (4): 727–37. PMID 9584986. 
  33. Lee, C; Pugh, TD; Klopp, RG; Edwards, J; Allison, DB; Weindruch, R; Prolla, TA (2004). "The impact of α-lipoic acid, coenzyme Q10 and caloric restriction on life span and gene expression patterns in mice". Free Radical Biology and Medicine 36 (8): 1043–57. doi:10.1016/j.freeradbiomed.2004.01.015. PMID 15059645. 
  34. Sohal, Rajindar S.; Kamzalov, Sergey; Sumien, Nathalie; Ferguson, Melissa; Rebrin, Igor; Heinrich, Kevin R.; Forster, Michael J. (2006). "Effect of coenzyme Q10 intake on endogenous coenzyme Q content, mitochondrial electron transport chain, antioxidative defenses, and life span of mice". Free Radical Biology and Medicine 40 (3): 480–7. doi:10.1016/j.freeradbiomed.2005.08.037. PMC 2834650. PMID 16443163. 
  35. Ishii, N; Senoo-Matsuda, N; Miyake, K; Yasuda, K; Ishii, T; Hartman, PS; Furukawa, S (2004). "Coenzyme Q10 can prolong C. elegans lifespan by lowering oxidative stress". Mechanisms of Ageing and Development 125 (1): 41–6. doi:10.1016/j.mad.2003.10.002. PMID 14706236. 
  36. Koryagin, A. S.; Krylova, E. V.; Luk'yanova, L. D. (2002). "Effect of ubiquinone-10 on the blood system in rats exposed to radiation". Bulletin of Experimental Biology and Medicine 133 (6): 562–564. doi:10.1023/A:1020225623808. PMID 12447465. 
  37. Shults, C. W.; Oakes, D; Kieburtz, K; Beal, MF; Haas, R; Plumb, S; Juncos, JL; Nutt, J et al. (2002). "Effects of Coenzyme Q10 in Early Parkinson Disease: Evidence of Slowing of the Functional Decline". Archives of Neurology 59 (10): 1541–50. doi:10.1001/archneur.59.10.1541. PMID 12374491.